fluorodeoxyglucose f18 has been researched along with Acinar Carcinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, Q; Wu, Y; Xiang, X; Zhou, J | 1 |
| Cai, J; Chen, H; Meng, T; Pang, Y; Xu, W | 1 |
| Cartenì, G; Fusco, M; Pirozzi, A; Riccardi, F; Scagliarini, S | 1 |
| Kardan, A; Short, RG | 1 |
| Makis, W; McCann, K; McEwan, AJ | 1 |
| Ban, MJ; Chang, JW; Choi, EC; Hong, HJ; Kim, WS; Koh, YW; Shin, YS | 1 |
| Reske, SN | 1 |
| Abasolo, I; Millán, O; Navarro, P; Pujal, J; Rabanal, RM; Real, FX; Serafin, A | 1 |
| Abe, K; Ishida, K; Mitamura, A; Miyazaki, S; Takahashi, S; Takanami, K; Yamada, S | 1 |
| Jang, SJ; Kim, KA; Kim, MJ | 1 |
| Baum, RP; Dietrich, C; Hör, G; Kirchner, J; Rink, T; Schröder, O; Zeuzem, S | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Acinar Carcinoma
| Article | Year |
|---|---|
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
10 other study(ies) available for fluorodeoxyglucose f18 and Acinar Carcinoma
| Article | Year |
|---|---|
Pancreatic Acinar Cell Carcinoma Presenting with Diffuse Pancreatic Enlargement.
Topics: Carcinoma, Acinar Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Pancreas; Pancreatic Neoplasms | 2022 |
Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CT.
Topics: Carcinoma, Acinar Cell; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals | 2023 |
Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Triptorelin Pamoate; Vincristine | 2019 |
18F-FDG PET/CT in a 16-year-old patient with hydranencephaly.
Topics: Adolescent; Carcinoma, Acinar Cell; Fluorodeoxyglucose F18; Humans; Hydranencephaly; Male; Multimodal Imaging; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Incidental Acinic Cell Carcinoma of the Parotid Gland Discordant on 123I-MIBG, 111In-Octreotide, and 18F-FDG PET/CT in a Patient With Neuroendocrine Tumor of the Cecum.
Topics: 3-Iodobenzylguanidine; Carcinoma, Acinar Cell; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Acinar Cell; Carcinoma, Mucoepidermoid; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Parotid Neoplasms; Prognosis; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2015 |
FDG PET imaging of Ela1-myc mice reveals major biological differences between pancreatic acinar and ductal tumours.
Topics: Animals; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Elongin; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, myc; Glucose Transport Proteins, Facilitative; Hexokinase; Male; Mice; Mice, Transgenic; Positron-Emission Tomography; RNA, Messenger; Transcription Factors | 2009 |
Two cases of 18 F-FDG PET/CT findings in acinar cell carcinoma of the pancreas.
Topics: Aged; Carcinoma, Acinar Cell; Contrast Media; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
A pancreatic mass presented with multiple hot spots in the subcutaneous fat layer on positron emission tomography. Acinar cell carcinoma with multiple fat necrosis.
Topics: Carcinoma, Acinar Cell; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Subcutaneous Fat; Tomography, X-Ray Computed | 2010 |
[Long-term follow-up and therapeutic control of a hepatic metastatic acinar cell carcinoma of the pancreas using FDG PET].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Ultrasonography | 1998 |